Researchers observed that only 8.3% of 24 children or adolescents with peanut allergy passed a double-blind placebo-controlled food challenge with at least 444 mg of peanut protein after receiving ...

Currently, there is no approved treatment or disease-modifying therapy for peanut allergy. This review discusses recent advances in molecular diagnostic techniques for peanut allergy and ...

semen (peanut)) for treatment of peanut allergy in patients aged one to three years, permitting earlier treatment for one of the most common food allergies. The extension to the marketing ...

semen (peanut)) for the treatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers all 27 European member states and the three ...

From the moment six-year-old Ryan Stamford wakes, to the moment he gets into bed at night, everything he touches and eats is potentially life-threatening. For Ryan suffers from severe peanut ...

“The study's findings contribute to our understanding of the potential role of dupilumab in managing peanut allergy and highlight the need for further research to optimize treatment strategies ...

“The approval of Palforzia® by the European Commission highlights the need for a treatment to help alleviate the burden of peanut allergy for young patients and their family,” said Michele ...

semen (peanut)) for the treatment of toddlers (ages 1 through 3) with a confirmed diagnosis of peanut allergy. The marketing authorisation covers all 27 European member states and the three European ...

The market opportunity for an effective peanut allergy treatment appears substantial. A recent allergist survey indicated high potential adoption rates for Viaskin Peanut, with physicians ...

Feeding Infants Peanut Products Protects Against Allergy Into Adolescence ... Our gut microbiome, an ecosystem of ... A Safer Treatment Path for High-Risk Children to Overcome Food Allergies ...